R1 RCM (NASDAQ:RCM) Shares Cross Above 200 Day Moving Average – What’s Next?

R1 RCM Inc. (NASDAQ:RCM) passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $13.25 and traded as high as $14.29. R1 RCM shares last traded at $14.28, with a volume of 1,997,833 shares changing hands.

Analyst Ratings Changes

A number of analysts have issued reports on RCM shares. Leerink Partnrs lowered R1 RCM from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. Canaccord Genuity Group reissued a “buy” rating and issued a $15.00 target price on shares of R1 RCM in a research report on Monday, July 22nd. Leerink Partners lowered R1 RCM from an “outperform” rating to a “market perform” rating and cut their target price for the company from $17.00 to $14.30 in a research report on Thursday, August 1st. Cantor Fitzgerald reissued a “neutral” rating and issued a $14.30 target price on shares of R1 RCM in a research report on Friday, October 4th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on R1 RCM from $14.00 to $16.00 and gave the company a “hold” rating in a research report on Tuesday, July 9th. Thirteen equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, R1 RCM presently has an average rating of “Hold” and a consensus target price of $15.41.

R1 RCM Price Performance

The stock has a fifty day simple moving average of $14.17 and a 200-day simple moving average of $13.25. The company has a market capitalization of $6.03 billion, a PE ratio of -142.80 and a beta of 0.84. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.77.

R1 RCM (NASDAQ:RCM) last released its quarterly earnings data on Wednesday, August 7th. The healthcare provider reported ($0.02) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.03. R1 RCM had a negative net margin of 1.68% and a negative return on equity of 1.44%. The company had revenue of $627.90 million for the quarter, compared to analysts’ expectations of $633.10 million. The company’s revenue was up 12.0% on a year-over-year basis. Equities analysts anticipate that R1 RCM Inc. will post -0.37 earnings per share for the current year.

Institutional Trading of R1 RCM

Hedge funds and other institutional investors have recently made changes to their positions in the company. Advisors Asset Management Inc. acquired a new position in shares of R1 RCM in the 1st quarter valued at $27,000. GAMMA Investing LLC raised its holdings in shares of R1 RCM by 41.3% in the third quarter. GAMMA Investing LLC now owns 2,597 shares of the healthcare provider’s stock valued at $37,000 after buying an additional 759 shares during the last quarter. Allspring Global Investments Holdings LLC raised its holdings in shares of R1 RCM by 589.2% in the third quarter. Allspring Global Investments Holdings LLC now owns 3,122 shares of the healthcare provider’s stock valued at $44,000 after buying an additional 2,669 shares during the last quarter. ANTIPODES PARTNERS Ltd acquired a new stake in shares of R1 RCM during the second quarter worth about $86,000. Finally, Values First Advisors Inc. purchased a new position in shares of R1 RCM during the third quarter worth about $88,000. Institutional investors and hedge funds own 61.10% of the company’s stock.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.